Immune checkpoint inhibitors induce response in a dose-dependent manner while their immune related adverse events are dose-independent, a meta-analysis

被引：0
|
作者：
Rahma, Osama [1 ]
Reuss, Joshua [2 ]
Giobbie-Hurder, Anita [1 ]
Razavi, Ghazaleh [3 ]
Mehra, Pooja [4 ]
Gupta, Seema [5 ]
Elias, Rawad [6 ]
Khleif, Samir [5 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Johns Hopkins Univ, Baltimore, MD USA
[3] Georgia Canc Ctr, Augusta, GA USA
[4] Univ Virginia, Charlottesville, VA USA
[5] Georgetown Univ, Washington, DC USA
[6] Hartford Healthcare, Hartford, CT USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2019年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P265
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Analysis of immune-related adverse events in gastrointestinal malignancy patients treated with immune checkpoint inhibitors
    Niu, Chengu
    Zhu, Kaiwen
    Zhang, Jing
    Joshi, Utsav
    Liu, Hongli
    Zahid, Salman
    Jadhav, Nagesh
    Okolo, Patrick I.
    INTERNATIONAL JOURNAL OF CANCER, 2024, 154 (07) : 1261 - 1271
  • [42] Analysis and evaluation of factors contributing to the occurrence of immune-related adverse events with immune checkpoint inhibitors
    Nagase, T.
    Shima, O.
    Maruhana, N.
    Miyazawa, Y.
    Yoshino, S.
    Sato, J.
    Yamada, H.
    Shinozaki, K.
    Ikeda, K.
    PHARMAZIE, 2024, 79 (7-8): : 163 - 168
  • [43] Adverse events of immune checkpoint inhibitors for patients with digestive system cancers: A systematic review and meta-analysis
    Kou, Liqiu
    Wen, Qinglian
    Xie, Xiaolu
    Chen, Xiu
    Li, Jun
    Li, Yaling
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [44] Adverse events associated with immune checkpoint inhibitors in patients with breast cancer: A systematic review and meta-analysis
    Balibegloo, Maryam
    Nejadghaderi, Seyed Aria
    Sadeghalvad, Mona
    Soleymanitabar, Alireza
    Nezamabadi, Sasan Salehi
    Saghazadeh, Amene
    Rezaei, Nima
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 96
  • [45] Association among major adverse cardiovascular events with immune checkpoint inhibitors: A systematic review and meta-analysis
    Li, Haixia
    Zheng, Yanfei
    Li, Bin
    Zhi, Yinghao
    Chen, Mingxian
    Zeng, Jing
    Jiao, Qian
    Tao, Yuxuan
    Liu, Xinmei
    Shen, Zican
    Zhang, Jiahui
    Zhao, Weizhe
    Chen, Dong
    JOURNAL OF INTERNAL MEDICINE, 2025, 297 (01) : 36 - 46
  • [46] USE OF IMMUNE CHECKPOINT INHIBITORS AND RISK OF IMMUNE-RELATED ADVERSE EVENTS AMONG PATIENTS WITH ADVANCED MELANOMA: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
    Chang, C. Y.
    Park, H.
    Lo-Ciganic, W.
    VALUE IN HEALTH, 2019, 22 : S89 - S89
  • [47] A comprehensive meta-analysis of endocrine immune-related adverse events of immune checkpoint inhibitors and outcomes in head and neck cancer and lung cancer.
    Gomes-Lima, Cristiane Jeyce
    Kwagvan, John
    King, Fred
    Fernandez, Stephen J.
    Burman, Kenneth D.
    Veytsman, Irina
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [48] Risk and incidence of fatal adverse events associated with immune checkpoint inhibitors: a systematic review and meta-analysis
    Jiang, Yi
    Zhang, Ning
    Pang, Hailin
    Gao, Xiaobo
    Zhang, Helong
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2019, 15 : 293 - 302
  • [49] Neutrophil to Lymphocyte ratio as a predictor for immune-related adverse events in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
    Zhang, Wei
    Tan, Yifei
    Li, Yuquan
    Liu, Jiang
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [50] Use of immune checkpoint inhibitors and risk of immune-related adverse events among patients with advanced melanoma: A systematic review and network meta-analysis
    Chang, Ching-Yuan
    Wang, Ching-Yu
    Park, Haesuk
    Lo-Ciganic, Wei-Hsuan
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 472 - 473
12345